
14.33 Delayed Data As of Jul 06 | ![]() Today’s Change | 12.45 Today|||52-Week Range 18.45 | +8.07% Year-to-Date |
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted Jun 30 / Zacks.com - Paid Partner Content | Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Jun 24 / Zacks.com - Paid Partner Content |
The Zacks Analyst Blog Highlights UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt Jun 27 / Zacks.com - Paid Partner Content | Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Jun 24 / Zacks.com - Paid Partner Content |
Top Analyst Reports for UnitedHealth, Chevron & AstraZeneca Jun 24 / Zacks.com - Paid Partner Content |
Previous close | 14.36 |
Today’s open | 14.29 |
Day’s range | 14.21 - 14.41 |
Volume | 708,830 |
Average volume (3 months) | 596,611 |
Market cap | $59.0B |
Earnings growth (last year) | -- |
Earnings growth (this year) | +6.45% |
Earnings growth (next 5 years) | +3.50% |
Revenue growth (last year) | +10.40% |
P/E ratio | -- |
Price/Sales | 1.01 |
Price/Book | 1.57 |
No competitors data available. |
Next reporting date | August 4, 2022 |
EPS forecast (this quarter) | $0.49 |
Annual revenue (last year) | $52.1B |
Annual profit (last year) | $1.2B |
Net profit margin | 2.27% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |